Team reports major step forward in cell reprogramming

(PhysOrg.com) -- A team of Harvard Stem Cell Institute (HSCI) researchers has made a major advance toward producing induced pluripotent stem cells, or iPS cells, that are safe enough to use in treating diseases in patients.

'Paintable' chemotherapy shrinks skin tumors in mice

Skin acts as the first line of defense against pathogens and other harmful material from outside the body. Yet this barrier also excludes some beneficial drugs that could treat skin diseases. Now, researchers have taken the ...

page 2 from 2